Barcelona Supercomputing Center creates AI model to analyze art pieces
Project in collaboration with Prado Museum detects content and symbolisms from the past
Project in collaboration with Prado Museum detects content and symbolisms from the past
Network of six will be available from second half of 2023 for R&D purposes for scientists, industries and even public sector across continent
ALBA Synchrotron and Barcelona Supercomputing Center are key contributions to global scientific effort
10-year project will design chips for zettascale supercomputers 1,000 times faster than today's
Inauguration, initially planned for early 2021, pending due to Covid-19 and bureaucratic problems
Government strives for ALBA synchrotron to continue being “a reference in Europe”
Everything you need to know about Barcelona’s new €200 million Mare Nostrum 5
EU to grant 100 million in project which will include a platform to create European processors
European Commission awards Catalan capital one of three new supercomputers in 2021
Sixteen countries support one of the three proposals, five of which have committed to Barcelona
BSC-CNS seeks EU funding to build model competing with those in China, the US, and Japan
The project will receive 240 million euros from European funds
A new computational method allows the detection, within just a few hours, of the genetic alterations responsible for the formation and progression of cancer tumours. This new method manages to accurately identify almost all types of genetic changes of cancer cells in a simple, quick and precise way. It is also able to identify large-scale chromosome rearrangements, which had been difficult to be detect until this breakthrough. The new method, called SMUFIN, has been developed by the Barcelona Supercomputing Centre and the ICREA (Catalan Institution of Research and Advanced Studies), in collaboration with research groups from Barcelona, Oviedo and Heidelberg. This progress has been published by the prestigious journal 'Nature Biotechnology' and represents a significant step forward towards the personalised treatment of cancer and other illnesses.